Newton, P.N., Bond, K.C., Adeyeye, M., Antignac, M., Ashenef, A., Awab, G.R., Babar, Z.-U.-D., Bannenberg, W.J., Bond, K.C., Bower, J., Breman, J., Brock, A., Caillet, C., Coyne, P., Day, N., Deats, M., Douidy, K., Doyle, K., Dujardin, C., Ejekam, C.S., Fernandez, F., Freifeld, C., Gill, M., Guerin, P.J., Harigwo, G., Heide, L., Horby, P., Kaur, H., Kayumba, P.C., Kazuko, K., Kelly, C., Khuluza, F., Kigera, S., Lalani, M., Lamy, M., Lieberman, M., Lumpkin, M., Mackey, T., Naughton, B., Newton, P.N., Nguyen, P., Ollario, P., Ozawa, S., Patel, A., Phanouvong, S., Pisani, E., Rago, L., Rahman, M.S., Ranjit, E., Ravinetto, R., Richmond, D., Singh-Phulgenda, S., Venema, J., Vogt, A., White, N., Wirtz, V., Zaman, M., 2020. COVID-19 and risks to the supply and quality of tests, drugs, and vaccines. THE LANCET GLOBAL HEALTH. https://doi.org/10.1016/S2214-109X(20)30136-4
Naughton, BD. 2020. In a time of pandemic, we need to stamp out quackery. OXFORD ANSWERS RESEARCH BLOG. https://www.sbs.ox.ac.uk/oxford-answers/time-pandemic-we-need-stamp-out-quackery
Newton, P.N., Bond, K.C., 2019. Global access to quality-assured medical products: the Oxford Statement and call to action. THE LANCET GLOBAL HEALTH. 7, e1609–e1611. https://doi.org/10.1016/S2214-109X(19)30426-7
Naughton and Foss. 2019. Responsible innovation and commercialisation in the university context: a case study of an academic entrepreneur in digital healthcare, In Responsible Innovation in Digital Health, Empowering the Patient. EDWARD ELGAR.
https://www.elgaronline.com/view/edcoll/9781788975056/9781788975056.00020.xml
Naughton, B., Roberts, L., Dopson, S., Chapman, S., Brindley, D., 2016. Effectiveness of medicines authentication technology to detect counterfeit, recalled and expired medicines: a two-stage quantitative secondary care study. BMJ Open 6, e013837. https://doi.org/10.1136/bmjopen-2016-013837
Naughton, B. The future of falsified and substandard medicine detection: digital methods to track and authenticate pharmaceutical products. PATHWAYS FOR PROSPERITY COMMISSION Background Paper Series; no. 5. Oxford, United Kingdom. Available from https://pathwayscommission.bsg.ox.ac.uk/sites/default/files/2018-10/naughton-medicine_detection_final.pdf
Naughton, B. The Falsified Medicines Directive (FMD) pilot: Medicine Authentication Technology in a Hospital setting. February 2017. HOSPITAL PHARMACY EUROPE
Naughton B, Koshkouei M, Brindley D et al. International Counterfeit Medicine Regulation (In Fundamentals of International Regulatory Affairs, 3rd Edition). January 2017. REGULATORY AFFAIRS PROFESSIONAL SOCIETY
Naughton B. Abstract: Effectiveness of Medicines Authentication Technology to Detect Counterfeit, Recalled and Expired Medicines: A Two-Stage Quantitative Secondary Care Study. June 2017. JPAG
Naughton B, Roberts L, Dopson S. Medicine Authentication Technology as a Counterfeit Medicine-detection tool: A Delphi Method Study to Establish Expert Opinion on Manual Medicine Authentication Technology in Secondary Care. May 2017. BMJ OPEN
Naughton B, (author and contributor).Oxford Handbook of Clinical Pharmacy. June 2017. OXFORD UNIVERSITY PRESS
Naughton B, Koshkouei M, Brindley D. Traceability and Supply Chain In the 10th edition of Fundamentals of US Regulatory Affairs. May 2017. REGULATORY AFFAIRS PROFESSIONAL SOCIETY
Book Excerpt: Fundamentals of EU Regulatory Affairs, Eighth Edition, Chapter 8: European Union Falsified Medicines Directive: Requirements and Implications for Multi-Stakeholder Healthcare Delivery. December 2015. REGULATORY AFFAIRS PROFESSIONAL SOCIETY
Naughton BD. The EU Falsified Medicines Directive: key implications for dispensers. Med Access @ point care [Internet]. 2017 Dec 23 [cited 2018 Jan 1];1(1). Available from: http://medicine-access.pointofcarejournals.com/article/f44f56ed-a619-4935-8c49-b7524265a973?permalink=f44f56ed-a619-4935-8c49-b7524265a973
Pettit D, Raza S, Naughton B, et al. The Limitations of QALY: A Literature Review. March 2016. JOURNAL OF STEM CELL RESEARCH AND THERAPY
Naughton B, Vadher B, Smith J, et al. EU Falsified Medicines Directive Mandatory Requirements for Secondary Care: A Concise Review. April 2016. JOURNAL OF GENERIC MEDICINE
Naughton, B, Dopson S, Chapman S, et al. Combatting Counterfeit Medicines: Legal Frameworks and Emerging Technologies. May 2016. REGULATORY AFFAIRS PROFESSIONAL SOCIETY
Naughton B. The Impact of the EU Falsified Medicines Directive on Secondary Care. May 2016. HOSPITAL PHARMACY EUROPE
Merks P, Swieczkowski D, Byliniak M,et al. The European Falsified Medicines Directive in Poland: background, implementation and potential recommendations for pharmacists. July 2016. EUROPEAN JOURNAL OF HOSPITAL PHARMACY
Naughton B, Roberts L, Dopson S. Effectiveness of Medicines Authentication Technology to Detect Counterfeit, Recalled and Expired Medicines: A Two-Stage Quantitative Secondary Care Study. December 2016. BMJ OPEN
Roberts, L.H., White, D., Vadher, B. What can Cognitive Behavioural Therapy (CBT) do for patient consultations? A feasibility study to examine the adoption of CBT techniques and their impact on clinical practice in the community pharmacy environment. NHS EXPO, Sept, 2016.
White, D., Roberts, L.H., Rakovshik, S., Vadher, B. Horne, R. Cognitive Behavioural Therpay Training for Medicines Related Consultations – A Qualitative Analysis. An Oxford Academic Health Science Network (AHSN) Project. Evidence Live! June, 2016.
White, D., Roberts, L.H., Rakovshik, S., Vadher, B. Horne, R. Transforming Patient Consultations through Cognitive Behavioural Therapy (CBT)-based Techniques in Community Pharmacy. Evidence Live! June, 2016.
Roberts, L.H., Tutcher, D., Vadher, B., Trower, C. Transforming Communication through Transfers of Care between Hospital and Community Pharmacy: An Oxford Academic Health Science Network (AHSN) Initiative in Partnership with PharmOutcomes. BioTrinity, April, 2016.
Naughton BD, Smith JA, Brindley DA. Establishing good authentication practice (GAP) in secondary care to protect against falsified medicines and improve patient safety. Eur J Hosp Pharm. 2016 Mar 1;23(2):118–20
Book Excerpt: Fundamentals of EU Regulatory Affairs, Seventh Edition, Chapter 8: European Union Falsified Medicines Directive: Requirements and Implications for Multi-Stakeholder Healthcare Delivery. December 2015. REGULATORY AFFAIRS PROFESSIONAL SOCIETY
Roberts, L.H., Teasdale, S., Vadher, B., Crowley, C., Bailey, J., Vincent, V. Subcutaneous Insulin Harm Reduction: An Oxford Academic Health Science Network (AHSN) Project. Patient Safety Federation Final Showcase Event, 2015.
Roberts, L.H., Vadher, B., Tutcher, D. Pharmacy Transfer of Care Project – Supporting Patients on Discharge from Hospital. Transformation Programme – Project Showcase Event, Oxford University Hospitals NHS Trust, July, 2015.